Published in N Engl J Med on June 04, 2009
Anakinra for Inflammatory Pustular Skin Diseases | NCT01794117
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood (2011) 5.61
An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med (2009) 4.97
The IL-1 family: regulators of immunity. Nat Rev Immunol (2010) 4.65
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov (2012) 4.40
The interleukin-1 family: back to the future. Immunity (2013) 3.90
Anti-inflammatory Agents: Present and Future. Cell (2010) 3.13
Autoinflammatory disease reloaded: a clinical perspective. Cell (2010) 3.04
IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol (2010) 2.99
Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet (2011) 2.21
IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells. J Exp Med (2012) 2.11
Why not treat human cancer with interleukin-1 blockade? Cancer Metastasis Rev (2010) 1.96
Interleukin-18 and IL-18 binding protein. Front Immunol (2013) 1.93
Treating inflammation by blocking interleukin-1 in humans. Semin Immunol (2013) 1.75
Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci Transl Med (2011) 1.74
Interleukin-1beta and the autoinflammatory diseases. N Engl J Med (2009) 1.63
Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J Clin Invest (2012) 1.58
Hypomorphic Rag mutations can cause destructive midline granulomatous disease. Blood (2010) 1.47
Therapy of autoinflammatory syndromes. J Allergy Clin Immunol (2009) 1.45
Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. J Exp Med (2014) 1.41
Monogenic autoinflammatory diseases: concept and clinical manifestations. Clin Immunol (2013) 1.40
The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation. Nat Immunol (2017) 1.38
Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses. J Allergy Clin Immunol (2009) 1.38
Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1. Clin Exp Immunol (2012) 1.30
Blocking interleukin-1 in rheumatic diseases. Ann N Y Acad Sci (2009) 1.25
Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis. Curr Opin Rheumatol (2010) 1.23
Efficacy of anti-IL-1 treatment in Majeed syndrome. Ann Rheum Dis (2012) 1.17
Canakinumab. MAbs (2010) 1.16
Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr Rheumatol Rep (2012) 1.12
The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases. Front Immunol (2013) 1.11
IL-1 blockade in autoinflammatory syndromes. Annu Rev Med (2014) 1.10
Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu Rev Immunol (2015) 1.08
Clinical, Molecular, and Genetic Characteristics of PAPA Syndrome: A Review. Curr Genomics (2010) 1.08
A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil. Arthritis Rheum (2011) 1.04
Immune modulation: IL-1, master mediator or initiator of inflammation. Nat Med (2009) 1.02
Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies. Rheumatology (Oxford) (2015) 1.01
TIR8/SIGIRR is an Interleukin-1 Receptor/Toll Like Receptor Family Member with Regulatory Functions in Inflammation and Immunity. Front Immunol (2012) 0.99
Alterations in the self-renewal and differentiation ability of bone marrow mesenchymal stem cells in a mouse model of rheumatoid arthritis. Arthritis Res Ther (2010) 0.98
Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation. Rheum Dis Clin North Am (2013) 0.98
Interferon regulatory factor 3 plays an anti-inflammatory role in microglia by activating the PI3K/Akt pathway. J Neuroinflammation (2011) 0.98
Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response. Curr Allergy Asthma Rep (2011) 0.97
Autoinflammatory pustular neutrophilic diseases. Dermatol Clin (2013) 0.97
Whole-genome copy number variation analysis in anophthalmia and microphthalmia. Clin Genet (2013) 0.97
Decoys and Regulatory "Receptors" of the IL-1/Toll-Like Receptor Superfamily. Front Immunol (2013) 0.96
Potential novel mechanism for Axenfeld-Rieger syndrome: deletion of a distant region containing regulatory elements of PITX2. Invest Ophthalmol Vis Sci (2011) 0.95
Deficiency of interleukin-1 receptor antagonist responsive to anakinra. Pediatr Dermatol (2012) 0.93
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. Mediators Inflamm (2013) 0.93
Interleukin 1 receptor antagonist deficiency presenting as infantile pustulosis mimicking infantile pustular psoriasis. Arch Dermatol (2012) 0.92
Autoinflammation: translating mechanism to therapy. J Leukoc Biol (2011) 0.91
Chronic cutaneous pustulosis due to a 175-kb deletion on chromosome 2q13: excellent response to anakinra. Arch Dermatol (2012) 0.91
After GWAS: mice to the rescue? Curr Opin Immunol (2012) 0.91
Exome sequencing reveals RAG1 mutations in a child with autoimmunity and sterile chronic multifocal osteomyelitis evolving into disseminated granulomatous disease. J Clin Immunol (2013) 0.90
IL-1 receptor antagonist-deficient mice develop autoimmune arthritis due to intrinsic activation of IL-17-producing CCR2(+)Vγ6(+)γδ T cells. Nat Commun (2015) 0.90
The SAPHO syndrome revisited with an emphasis on spinal manifestations. Skeletal Radiol (2014) 0.89
HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins. Cell Mol Immunol (2016) 0.89
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives. Mediators Inflamm (2015) 0.89
Autoinflammatory bone disorders: update on immunologic abnormalities and clues about possible triggers. Curr Opin Rheumatol (2013) 0.88
A role of IL-1R1 signaling in the differentiation of Th17 cells and the development of autoimmune diseases. Self Nonself (2011) 0.87
Genetic determinants of circulating interleukin-1 receptor antagonist levels and their association with glycemic traits. Diabetes (2014) 0.86
Direct inhibition of human RANK+ osteoclast precursors identifies a homeostatic function of IL-1beta. J Immunol (2010) 0.85
A novel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onset. Clin Immunol (2012) 0.85
Untangling the web of systemic autoinflammatory diseases. Mediators Inflamm (2014) 0.85
DIRA, DITRA, and new insights into pathways of skin inflammation: what's in a name? Arch Dermatol (2012) 0.84
When less is more: primary immunodeficiency with an autoinflammatory kick. Curr Opin Allergy Clin Immunol (2014) 0.84
Monogenic IL-1 mediated autoinflammatory and immunodeficiency syndromes: finding the right balance in response to danger signals. Clin Immunol (2010) 0.84
Impact of IL-1 signalling on experimental uveitis and arthritis. Ann Rheum Dis (2012) 0.84
Autoinflammatory bone diseases. Rheum Dis Clin North Am (2013) 0.84
Mutations in the IL1RN locus lead to autoinflammation. Nat Rev Rheumatol (2009) 0.82
An expanding role for interleukin-1 blockade from gout to cancer. Mol Med (2014) 0.82
NLRP3 activation induces ASC-dependent programmed necrotic cell death, which leads to neutrophilic inflammation. Cell Death Dis (2013) 0.81
Deficiency of interleukin-1-receptor antagonist syndrome: a rare auto-inflammatory condition that mimics multiple classic radiographic findings. Pediatr Radiol (2011) 0.81
Sequencing and comparative genomic analysis of 1227 Felis catus cDNA sequences enriched for developmental, clinical and nutritional phenotypes. BMC Genomics (2012) 0.80
Periodic fever syndrome and autoinflammatory diseases. F1000 Med Rep (2010) 0.80
Anti-inflammatory panacea? The expanding therapeutics of interleukin-1 blockade. Curr Opin Rheumatol (2016) 0.80
New discoveries in CRMO: IL-1β, the neutrophil, and the microbiome implicated in disease pathogenesis in Pstpip2-deficient mice. Semin Immunopathol (2015) 0.79
Impaired cytokine responses in patients with cryopyrin-associated periodic syndrome (CAPS). Clin Exp Immunol (2014) 0.79
Interleukin-1 Family Cytokines in Liver Diseases. Mediators Inflamm (2015) 0.79
Identification of potential small molecule allosteric modulator sites on IL-1R1 ectodomain using accelerated conformational sampling method. PLoS One (2015) 0.78
The expanding spectrum of rare monogenic autoinflammatory diseases. Orphanet J Rare Dis (2013) 0.78
Anakinra as an interleukin 1 receptor antagonist, complicated genetics and molecular impacts--from the point of view of mouse genomics. Int Immunopharmacol (2012) 0.78
Prediction of candidate primary immunodeficiency disease genes using a support vector machine learning approach. DNA Res (2009) 0.78
Genome-wide association studies--a summary for the clinical gastroenterologist. World J Gastroenterol (2009) 0.78
Interleukin-1 receptor blockade in perinatal brain injury. Front Pediatr (2014) 0.78
Update on the treatment of juvenile idiopathic arthritis. Curr Allergy Asthma Rep (2013) 0.77
Targeting the inflammasome in rheumatic diseases. Transl Res (2015) 0.77
The role of IL-1β in the bone loss during rheumatic diseases. Mediators Inflamm (2015) 0.76
Interleukin-1 (IL-1) signaling in intestinal stromal cells controls KC/ CXCL1 secretion, which correlates with recruitment of IL-22- secreting neutrophils at early stages of Citrobacter rodentium infection. Infect Immun (2015) 0.76
Regulatory Role of IL-1R8 in Immunity and Disease. Front Immunol (2016) 0.76
Intracellular function of interleukin-1 receptor antagonist in ischemic cardiomyocytes. PLoS One (2013) 0.76
Dermatologic Manifestations of Monogenic Autoinflammatory Diseases. Dermatol Clin (2017) 0.75
Whole genome sequencing identifies missense mutation in MTBP in Shar-Pei affected with Autoinflammatory Disease (SPAID). BMC Genomics (2017) 0.75
Genetically defined autoinflammatory diseases. Oral Dis (2016) 0.75
Primary Chronic Osteomyelitis of the Jaws in Children: An Update on Pathophysiology, Radiological Findings, Treatment Strategies, and Prospective Analysis of Two Cases. Case Rep Dent (2015) 0.75
Autoinflammation and HLA-B27: Beyond Antigen Presentation. Ocul Immunol Inflamm (2016) 0.75
Autoimmune valvular carditis. Curr Allergy Asthma Rep (2015) 0.75
Interleukin-1 receptor antagonist deficiency with a novel mutation; late onset and successful treatment with canakinumab: a case report. J Med Case Rep (2015) 0.75
An autoinflammatory neurological disease due to interleukin 6 hypersecretion. J Neuroinflammation (2013) 0.75
Phosphodiesterase 4B negatively regulates endotoxin-activated interleukin-1 receptor antagonist responses in macrophages. Sci Rep (2017) 0.75
Microbiota and caspase-1/caspase-8 regulate IL-1β-mediated bone disease. Gut Microbes (2016) 0.75
Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations. Front Immunol (2017) 0.75
Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases. Front Pharmacol (2017) 0.75
NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity (2004) 13.55
Genesis: cluster analysis of microarray data. Bioinformatics (2002) 10.50
Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet (2001) 9.34
Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum (2004) 7.07
De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum (2002) 4.98
An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med (2009) 4.97
Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity (2004) 4.11
Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med (2000) 4.06
A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients. Scand J Rheumatol Suppl (1987) 2.62
Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J Biol Chem (2004) 2.60
Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med (2007) 2.59
Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med (2000) 2.50
The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr Opin Rheumatol (2003) 2.04
Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2. J Immunol (2001) 2.03
Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev (2007) 2.01
Arthropathy with rash, chronic meningitis, eye lesions, and mental retardation. J Pediatr (1981) 1.79
Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome patients. Blood (2007) 1.69
A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomics (2002) 1.58
Genomic organization of the interleukin-1 locus. Genomics (2002) 1.48
The role of interleukin-1 in bone resorption in rheumatoid arthritis. Rheumatology (Oxford) (2004) 1.29
Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist. J Invest Dermatol (2004) 1.26
Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med (2011) 9.03
A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity (2011) 3.76
Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation (2005) 2.81
Half-Heusler ternary compounds as new multifunctional experimental platforms for topological quantum phenomena. Nat Mater (2010) 2.45
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation. Clin Pharmacol Ther (2013) 2.39
Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan. J Pediatr (2007) 1.92
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Development and use of active clinical decision support for preemptive pharmacogenomics. J Am Med Inform Assoc (2013) 1.80
Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease. Blood (2009) 1.80
Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans. Hum Mol Genet (2012) 1.77
Quantitative quality control in microarray experiments and the application in data filtering, normalization and false positive rate prediction. Bioinformatics (2003) 1.73
Statewide newborn screening for severe T-cell lymphopenia. JAMA (2009) 1.68
Novel genetic variants contributing to left ventricular hypertrophy: the HyperGEN study. J Hypertens (2009) 1.61
Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. Annu Rev Pharmacol Toxicol (2014) 1.58
Genome-wide association analysis of blood-pressure traits in African-ancestry individuals reveals common associated genes in African and non-African populations. Am J Hum Genet (2013) 1.55
Gene targeting in NOD mouse embryos using zinc-finger nucleases. Diabetes (2013) 1.52
Fetal lung interstitial tumor (FLIT): A proposed newly recognized lung tumor of infancy to be differentiated from cystic pleuropulmonary blastoma and other developmental pulmonary lesions. Am J Surg Pathol (2010) 1.52
PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics. Am J Med Genet C Semin Med Genet (2014) 1.49
Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics. J Immunol (2008) 1.43
Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice. J Clin Invest (2010) 1.41
Human gene copy number spectra analysis in congenital heart malformations. Physiol Genomics (2012) 1.30
CARD15 gene mutations and risk for early surgery in pediatric-onset Crohn's disease. Clin Gastroenterol Hepatol (2004) 1.25
Genome-wide association of body fat distribution in African ancestry populations suggests new loci. PLoS Genet (2013) 1.24
Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease. Blood (2008) 1.24
Extremes of clinical and enzymatic phenotypes in children with hyperinsulinism caused by glucokinase activating mutations. Diabetes (2009) 1.23
An arrayed high-content chemotaxis assay for patient diagnosis. Integr Biol (Camb) (2010) 1.22
Impaired survival of peripheral T cells, disrupted NK/NKT cell development, and liver failure in mice lacking Gimap5. Blood (2008) 1.19
BMP4 loss-of-function mutations in developmental eye disorders including SHORT syndrome. Hum Genet (2011) 1.18
Genome-wide association study identifies single-nucleotide polymorphism in KCNB1 associated with left ventricular mass in humans: the HyperGEN Study. BMC Med Genet (2009) 1.17
Implementing routine testing for severe combined immunodeficiency within Wisconsin's newborn screening program. Public Health Rep (2010) 1.15
Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and White children with Crohn's disease. Inflamm Bowel Dis (2005) 1.11
IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapy. J Immunol (2012) 1.11
PITX2 and FOXC1 spectrum of mutations in ocular syndromes. Eur J Hum Genet (2012) 1.10
Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation. J Clin Endocrinol Metab (2004) 1.09
Effect of high glucose on gene expression in mesangial cells: upregulation of the thiol pathway is an adaptational response. Physiol Genomics (2004) 1.08
Pediatric inflammatory bowel disease: clinical and molecular genetics. Inflamm Bowel Dis (2007) 1.05
Genotyping platforms for mass-throughput genotyping with SNPs, including human genome-wide scans. Adv Genet (2008) 1.05
Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE. J Autoimmun (2012) 1.03
Pediatric onset Crohn's colitis is characterized by genotype-dependent age-related susceptibility. Inflamm Bowel Dis (2007) 1.01
Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity. Blood (2002) 1.00
Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice. J Clin Invest (2009) 0.98
The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease. Am J Physiol Gastrointest Liver Physiol (2011) 0.98
Evidence of transmission ratio distortion of DLG5 R30Q variant in general and implication of an association with Crohn disease in men. Hum Genet (2006) 0.98
Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man. J Exp Med (2007) 0.97
Multifocal vulvar smooth muscle tumor with an unusual intravascular growth pattern and multiple local recurrences in a 10-year-old child: a diagnostic dilemma. Pediatr Dev Pathol (2010) 0.96
Involvement of eotaxin, eosinophils, and pancreatic predisposition in development of type 1 diabetes mellitus in the BioBreeding rat. J Immunol (2004) 0.96
B.E.A.R. GeneInfo: a tool for identifying gene-related biomedical publications through user modifiable queries. BMC Bioinformatics (2004) 0.96
Identification of a serum-induced transcriptional signature associated with type 1 diabetes in the BioBreeding rat. Diabetes (2010) 0.95
Potential novel mechanism for Axenfeld-Rieger syndrome: deletion of a distant region containing regulatory elements of PITX2. Invest Ophthalmol Vis Sci (2011) 0.95
Genes for left ventricular hypertrophy. Curr Hypertens Rep (2004) 0.93
MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin. J Urol (2009) 0.92
Evidence of a functional role for mast cells in the development of type 1 diabetes mellitus in the BioBreeding rat. J Immunol (2006) 0.92
DLG5 R30Q variant is a female-specific protective factor in pediatric onset Crohn's disease. Am J Gastroenterol (2006) 0.91
Human phagocyte defect caused by a Rac2 mutation detected by means of neonatal screening for T-cell lymphopenia. J Allergy Clin Immunol (2010) 0.91
A novel approach for high-quality microarray processing using third-dye array visualization technology. IEEE Trans Nanobioscience (2003) 0.90
Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease. Am J Gastroenterol (2006) 0.90
Genetic variation in NCAM1 contributes to left ventricular wall thickness in hypertensive families. Circ Res (2011) 0.89
Copy number variations associated with obesity-related traits in African Americans: a joint analysis between GENOA and HyperGEN. Obesity (Silver Spring) (2012) 0.89
Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes. Pharmacogenomics (2014) 0.89
Proximity-induced high-temperature superconductivity in the topological insulators Bi₂Se₃ and Bi₂Te₃. Nat Commun (2012) 0.89
Characterization of autosomal copy-number variation in African Americans: the HyperGEN Study. Eur J Hum Genet (2011) 0.88
Genetic determinants of hypertension: an update. Curr Hypertens Rep (2008) 0.87
Molecular targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) within the zebrafish ovary: insights into TCDD-induced endocrine disruption and reproductive toxicity. Reprod Toxicol (2007) 0.86
Detection of genomic polymorphisms associated with venous thrombosis using the invader biplex assay. J Mol Diagn (2004) 0.86
Comprehensive quality control utilizing the prehybridization third-dye image leads to accurate gene expression measurements by cDNA microarrays. BMC Bioinformatics (2006) 0.86
Differential effects of leptin receptor mutation on male and female BBDR Gimap5-/Gimap5- spontaneously diabetic rats. Physiol Genomics (2009) 0.85
Use of transcriptional signatures induced in lymphoid and myeloid cell lines as an inflammatory biomarker in Type 1 diabetes. Physiol Genomics (2011) 0.85
The role of genomics in the neonatal ICU. Clin Perinatol (2009) 0.84
Lymphotoxin-alpha and galectin-2 SNPs are not associated with myocardial infarction in two different German populations. J Mol Med (Berl) (2007) 0.84
SORCS1 contributes to the development of renal disease in rats and humans. Physiol Genomics (2013) 0.83
Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium. BMC Genomics (2004) 0.83
Screening newborns for primary T-cell immunodeficiencies: consensus and controversy. Expert Rev Clin Immunol (2011) 0.83
Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2011) 0.83
Epidemiology, risk factors, and genetics of high-altitude-related pulmonary disease. Clin Chest Med (2005) 0.83
Genotype imputation for African Americans using data from HapMap phase II versus 1000 genomes projects. Genet Epidemiol (2012) 0.83
Molecular characterization of histidinemia: identification of four missense mutations in the histidase gene. Hum Genet (2005) 0.83
Transcriptome analysis and kidney research: toward systems biology. Kidney Int (2005) 0.82
Multiplexed quantitative real-time PCR to detect 22q11.2 deletion in patients with congenital heart disease. Physiol Genomics (2010) 0.82
Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology. Pediatr Rheumatol Online J (2012) 0.82
Global analysis of phase locking in gene expression during cell cycle: the potential in network modeling. BMC Syst Biol (2010) 0.82
Genome-wide joint SNP and CNV analysis of aortic root diameter in African Americans: the HyperGEN study. BMC Med Genomics (2011) 0.82
Overexpression of fucosyltransferase IV in A431 cell line increases cell proliferation. Int J Biochem Cell Biol (2007) 0.81
Three-color cDNA microarrays with prehybridization quality control yield gene expression data comparable to that of commercial platforms. Physiol Genomics (2006) 0.81